Bupivacaine hydrochloride is a long-acting local or regional anesthesia used for surgical procedures.
Claris currently has 15 drug approvals, with 25 pending. The company expects more market approvals before the end of the year.
More articles on the drug market:
FDA expedites Merck’s experimental Ebola vaccine
Pills laced with fentanyl invade drug market
Patients in Texas and Florida gain easier access to opioid-overdose antidote naloxone
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
